Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation - Scorecard - MDSpire

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation

  • By

  • Yasuyuki Miyake

  • Shoichi Iriguchi

  • Ai Kawana-Tachikawa

  • Shuichi Kitayama

  • Eri Imai

  • Kahoru Taya

  • Hiroshi Ishii

  • Tomoyuki Miura

  • Hiromi Sakawaki

  • Tetsuro Matano

  • Shin Kaneko

  • May 27, 2026

  • 0 min

Share

Clinical Scorecard: Correction: A Non-Human Primate Model Demonstrates the Short-Term Safety and Feasibility of Autologous Transplantation Using iPSC-Derived Innate-Like T Cells

At a Glance

CategoryDetail
ConditionAutologous transplantation using iPSC-derived innate-like T cells
Key MechanismsiPSC-derived innate-like T cells
Target PopulationNon-human primates
Care SettingPreclinical model

Key Highlights

  • Feasibility of iPSC-derived innate-like T cells in transplantation
  • Short-term safety demonstrated in a non-human primate model
  • Correction made to funding statement

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable (non-human primate model)

          Short-term safety and feasibility of treatment assessed

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation

            • by Yasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, Shuichi Kitayama, Eri Imai, Kahoru Taya, Hiroshi Ishii, Tomoyuki Miura, Hiromi Sakawaki, Tetsuro Matano, Shin Kaneko

            • May 27, 2026

            Related Content

            Case Report: Hemophagocytic lymphohistiocytosis masquerading as drug-induced liver injury: successful treatment with low-dose ruxolitinib and glucocorticoids

            CD32b defines distinct dendritic cell lineages generated from the culture of bone marrow with GM-CSF

            When Insight Meets Urgency in Cell and Gene Therapy

            Balancing deep biological insight with the realities of development is now central to progress in advanced medicine